We are live on ! Find out more
OA

Oxbow Advisors Portfolio holdings

AUM $1.23B
1-Year Est. Return 23.59%
This Fund
S&P 500
This Quarter Est. Return
+20.42%
1 Year Est. Return
+23.59%
3 Year Est. Return
+66.32%
5 Year Est. Return
+74.19%
10 Year Est. Return
+150.46%
AUM
$687M
AUM Growth
+$92.3M
Cap. Flow
-$12.8M
Cap. Flow %
-1.86%
Top 10 Hldgs %
23.38%
Holding
294
New
20
Increased
47
Reduced
133
Closed
23
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPD icon
1
Enterprise Products Partners
EPD
$84.2B
$22.5M 3.27%
1,235,597
-35,293
-3% -$631K
MSFT icon
2
Microsoft
MSFT
$3.68T
$20M 2.92%
98,431
-4,796
-5% -$871K
AAPL icon
3
Apple
AAPL
$4.88T
$19.4M 2.82%
212,708
-2,144
-1% -$166K
IAU icon
4
iShares Gold Trust
IAU
$64.6B
$15.6M 2.26%
457,645
+120,055
+36% +$3.93M
MNRL
5
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
$15.2M 2.21%
1,230,070
-404,967
-25% -$4.92M
AVGOP
6
DELISTED
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
$14.8M 2.16%
13,322
-180
-1% -$187K
GGN
7
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$865M
$14.3M 2.08%
4,149,116
+502,605
+14% +$1.67M
UL icon
8
Unilever
UL
$134B
$13.5M 1.96%
218,076
+207,556
+1,973% +$12.4M
MA icon
9
Mastercard
MA
$499B
$13.2M 1.92%
44,646
+2,915
+7% +$822K
AMZN icon
10
Amazon
AMZN
$2.76T
$12.2M 1.77%
88,200
+38,760
+78% +$4.68M
GOOG icon
11
Alphabet (Google) Class C
GOOG
$4.13T
$11.8M 1.71%
166,420
+11,020
+7% +$744K
V icon
12
Visa
V
$692B
$10.6M 1.54%
54,804
+4,321
+9% +$789K
JNJ icon
13
Johnson & Johnson
JNJ
$640B
$10.3M 1.51%
73,597
+10,775
+17% +$1.57M
RSP icon
14
Invesco S&P 500 Equal Weight ETF
RSP
$98.5B
$10.1M 1.48%
99,582
-3,053
-3% -$294K
BAC.PRL icon
15
Bank of America Series L
BAC.PRL
$3.99B
$10M 1.46%
7,486
-200
-3% -$271K
C.PRN icon
16
Citigroup Capital XIII 7.875% Fixed Rate/Floating Rate Trust Preferred Securities
C.PRN
$2.36B
$10M 1.46%
+378,927
New +$10.2M
PFE icon
17
Pfizer
PFE
$157B
$9.97M 1.45%
321,425
+192,436
+149% +$6.54M
BDXB
18
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B
BDXB
$9.66M 1.41%
+181,535
New +$9.31M
OHI icon
19
Omega Healthcare
OHI
$14.3B
$9.43M 1.37%
+317,296
New +$9.4M
UN
20
DELISTED
Unilever NV New York Registry Shares
UN
$9.25M 1.35%
173,594
+2,217
+1% +$113K
KMI icon
21
Kinder Morgan
KMI
$68.9B
$8.93M 1.3%
588,745
-14,151
-2% -$215K
UNH icon
22
UnitedHealth
UNH
$340B
$8.7M 1.27%
29,502
+1,254
+4% +$359K
ACN icon
23
Accenture
ACN
$110B
$8.68M 1.26%
40,416
+218
+0.5% +$41.2K
NVS icon
24
Novartis
NVS
$262B
$8.66M 1.26%
+99,140
New +$8.56M
PAGP icon
25
Plains GP Holdings
PAGP
$5.54B
$8.49M 1.24%
953,812
+33,740
+4% +$297K

Similar funds

Oxbow Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Oxbow Advisors held 294 positions worth $687M, up 16% from $595M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Oxbow Advisors's Q2 2020 filing shows 20 new, 47 increased, 133 reduced and 23 closed positions. Its largest new stake was Citigroup Capital XIII 7.875% Fixed Rate/Floating Rate Trust Preferred Securities: 378,927 shares worth $10M. The largest sale was Tallgrass Energy, LP Class A Shares, an estimated $12.7M.

By sector, the portfolio is most concentrated in Miscellaneous at 36% of assets, down from 43% a quarter earlier, followed by Energy and Technology.

  • Oxbow Advisors's largest Q2 2020 buy was Citigroup Capital XIII 7.875% Fixed Rate/Floating Rate Trust Preferred Securities: 378,927 shares worth $10M.
  • Oxbow Advisors added most to Unilever in Q2 2020, an estimated $12.4M increase.
  • Oxbow Advisors's biggest Q2 2020 reduction was Nuveen Quality Municipal Income Fund, cutting an estimated $9.47M.
  • Oxbow Advisors fully exited Tallgrass Energy, LP Class A Shares in Q2 2020, selling an estimated $12.7M.
  • Oxbow Advisors's ten largest holdings make up 23% of its $687M portfolio in Q2 2020.
  • Oxbow Advisors opened 20 new positions and closed 23 in Q2 2020.
  • Oxbow Advisors's portfolio value rose 16% quarter-over-quarter to $687M.

Based on Oxbow Advisors's 13F filing for Q2 2020, filed 12 Aug 2020.